VERO
Venus Concept Inc
NASDAQ: VERO · HEALTHCARE · MEDICAL DEVICES
$0.31
+0.00% today
Updated 2026-04-30
Market cap
$578190.00
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-45.26
Dividend yield
—
52W range
$0 – $8
Volume
0.0M
Venus Concept Inc (VERO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $26.48M | $19.50M | $32.97M | $30.97M | $191.13M | $160.53M | $157.37M | $125.38M | $93.65M | $68.18M |
| Cash & equivalents | $17.13M | $11.91M | $23.55M | $16.12M | $15.67M | $34.30M | $30.88M | $11.57M | $5.40M | $4.27M |
| Current assets | $25.39M | $17.94M | $31.73M | $29.49M | $99.70M | $115.40M | $110.28M | $83.71M | $66.44M | $48.51M |
| Total liabilities | $148.68M | $163.04M | $19.78M | $29.39M | $114.45M | $116.76M | $115.78M | $116.64M | $107.10M | $65.35M |
| Current liabilities | $4.96M | $13.05M | $14.05M | $9.38M | $48.17M | $32.52M | $34.72M | $39.59M | $31.16M | $30.29M |
| Long-term debt | $19.71M | $13.00M | $5.27M | $19.42M | $61.23M | $79.60M | $77.33M | $70.00M | $70.79M | $31.44M |
| Shareholder equity | $-122.20M | $-143.54M | $13.19M | $1.58M | $74.18M | $44.23M | $40.94M | $8.09M | $-14.02M | $2.37M |
| Retained earnings | $-124.80M | $-146.65M | $-164.49M | $-193.21M | $-75.69M | $-157.39M | $-180.41M | $-224.10M | $-261.90M | $-308.90M |
| Accounts receivable | $1.49M | $2.48M | $3.86M | $6.57M | $58.98M | $56.35M | $49.65M | $39.49M | $30.57M | $19.33M |
| Inventory | $5.63M | $2.74M | $2.76M | $5.52M | $18.84M | $17.76M | $26.21M | $29.79M | $28.68M | $17.56M |
| Goodwill | — | — | — | $2.60M | $27.45M | $0.00 | — | — | — | — |